{"id":2887,"date":"2017-09-01T08:11:21","date_gmt":"2017-09-01T12:11:21","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=2887"},"modified":"2017-09-02T07:42:33","modified_gmt":"2017-09-02T11:42:33","slug":"ipo-pipeline-filings-begin-to-trickle-in-pre-labor-day","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-filings-begin-to-trickle-in-pre-labor-day\/","title":{"rendered":"IPO Pipeline: Filings begin to trickle in pre-Labor Day"},"content":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 62 active IPOs in the pipeline as of September 2, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

\"Screen<\/a><\/p>\n

NEW FILINGS<\/p>\n

Company: Secoo Holding Limited<\/strong>
\nSymbol: SECO
\nDescription: They are Asia’s largest online integrated upscale products and services platform as measured by GMV in 2016, according to the Frost & Sullivan report.
\nTrade Date: TBD
\nUnderwriter(s): Jefferies
\nFiled: 8-25-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Sol-Gel Technologies, Ltd.<\/strong>
\nSymbol: SLGL
\nDescription: They are a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, BMO Capital Markets
\nCo-Manager(s): JMP Securities, Raymond James
\nFiled: 8-29-17
\nListed Cash Raise: $86.25 million<\/p>\n

Company: RYB Education, Inc.<\/strong>
\nSymbol: RYB
\nDescription: They are the largest early childhood education service provider in China, as measured by annual total revenues in 2016, according to the Frost & Sullivan Report.
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, Morgan Stanley
\nCo-Manager(s): CICC
\nFiled: 8-30-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Nightstar Therapeutics Limited<\/strong>
\nSymbol: NITE
\nDescription: They are a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. v
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Leerink Partners, BMO Capital Markets
\nCo-Manager(s): Wedbush PacGrow, Chardan
\nFiled: 8-31-17
\nListed Cash Raise: $86.25 million<\/p>\n

Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b>Deciphera Pharmaceuticals<\/b>
\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0DCPH<\/span>
\nDescription: \u00a0\u00a0\u00a0They are a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of many cancer therapies. <\/span>
\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<\/span>
\nUnderwriter(s): \u00a0J.P. Morgan, Piper Jaffray<\/span>
\nCo-Manager(s): JMP Securities, Nomura<\/span>
\nFiled: 9-1-17<\/span><\/a>
\nListed Cash Raise: $100 million<\/span><\/p>\n

 <\/p>\n

Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b>Restoration Robotics, Inc.<\/b>
\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0HAIR<\/span>
\nDescription: \u00a0\u00a0\u00a0They are a medical technology company developing and commercializing a robotic device, the ARTAS System, that assists physicians in performing many of the repetitive tasks that are a part of a follicular unit extraction surgery, a type of hair restoration procedure. <\/span>
\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<\/span>
\nUnderwriter(s): \u00a0National Securities Corporation<\/span>
\nCo-Manager(s): Roth Capital Partners, Craig-Hallum Capital Group<\/span>
\nFiled: 9-1-17<\/span><\/a>
\nListed Cash Raise: $28.75 million<\/span><\/p>\n

 <\/p>\n

Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b>Roku, Inc.<\/b>
\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0ROKU<\/span>
\nDescription: \u00a0\u00a0\u00a0They pioneered streaming to the TV. Roku connects users to the streaming content they love, enables content publishers to build and monetize large audiences, and provides advertisers with unique capabilities to engage consumers.<\/span>
\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<\/span>
\nUnderwriter(s): \u00a0Morgan Stanley, Citigroup, Allen & Co., RBC Capital Markets<\/span>
\nCo-Manager(s): Needham & Co., Oppenheimer & Co., William Blair<\/span>
\nFiled: 9-1-17<\/span><\/a>
\nListed Cash Raise: $100 million<\/span><\/p>\n

 <\/p>\n

Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b>Nucana PLC<\/b>
\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0NCNA<\/span>
\nDescription: \u00a0\u00a0\u00a0They are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. <\/span>
\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<\/span>
\nUnderwriter(s): \u00a0Citigroup, Jefferies, Cowen<\/span>
\nCo-Manager(s): William Blair<\/span>
\nFiled: 9-1-17<\/span><\/a>
\nListed Cash Raise: $115 million<\/span><\/p>\n

UPDATED TERMS<\/p>\n

Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b>Zai Lab Limited<\/b>
\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0ZLAB<\/span>
\nDescription: \u00a0\u00a0\u00a0They are an innovative biopharmaceutical company based in Shanghai focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the areas of oncology, autoimmune and infectious diseases.<\/span>
\nShares: 5.88 million<\/span>
\nPrice Range: $16.00-$18.00<\/span>
\nTrade Date: \u00a0\u00a0\u00a0\u00a09\/20<\/span>
\nUnderwriter(s): \u00a0J.P. Morgan, Citigroup, Leerink Partners<\/span>
\nTerms Added: 9-1-17<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 62 active IPOs in the pipeline as of September 2, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS Company: Secoo[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-2887","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=2887"}],"version-history":[{"count":5,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2887\/revisions"}],"predecessor-version":[{"id":2894,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2887\/revisions\/2894"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=2887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=2887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=2887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}